Signals of anticipation of reward and of mean reward rates in the human brain.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
09 03 2020
Historique:
received: 24 09 2019
accepted: 23 02 2020
entrez: 11 3 2020
pubmed: 11 3 2020
medline: 24 11 2020
Statut: epublish

Résumé

Theoretical models of dopamine function stemming from reinforcement learning theory have emphasized the importance of prediction errors, which signal changes in the expectation of impending rewards. Much less is known about the effects of mean reward rates, which may be of motivational significance due to their role in computing the optimal effort put into exploiting reward opportunities. Here, we used a reinforcement learning model to design three functional neuroimaging studies and disentangle the effects of changes in reward expectations and mean reward rates, showing recruitment of specific regions in the brainstem regardless of prediction errors. While changes in reward expectations activated ventral striatal areas as in previous studies, mean reward rates preferentially modulated the substantia nigra/ventral tegmental area, deep layers of the superior colliculi, and a posterior pontomesencephalic region. These brainstem structures may work together to set motivation and attentional efforts levels according to perceived reward opportunities.

Identifiants

pubmed: 32152378
doi: 10.1038/s41598-020-61257-y
pii: 10.1038/s41598-020-61257-y
pmc: PMC7062891
doi:

Substances chimiques

Dopamine VTD58H1Z2X

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4287

Références

Neuroimage. 2011 Jan 1;54(1):313-27
pubmed: 20656036
Neuropsychopharmacology. 2010 Jan;35(1):27-47
pubmed: 19675534
Nat Rev Neurosci. 2006 Dec;7(12):967-75
pubmed: 17115078
Nature. 2001 Jul 5;412(6842):43-8
pubmed: 11452299
Nat Neurosci. 2003 Sep;6(9):968-73
pubmed: 12897785
Psychol Rev. 1974 May;81(3):199-213
pubmed: 4424766
Neuron. 2009 Jul 16;63(1):119-26
pubmed: 19607797
Neuropsychopharmacology. 2013 Jul;38(8):1495-503
pubmed: 23419875
Cereb Cortex. 2012 Mar;22(3):607-15
pubmed: 21680848
AJNR Am J Neuroradiol. 2002 Nov-Dec;23(10):1747-56
pubmed: 12427635
Science. 2007 May 11;316(5826):904-6
pubmed: 17431137
Mov Disord. 2016 May;31(5):615-24
pubmed: 26880095
Biol Psychiatry. 2006 Jun 15;59(12):1151-9
pubmed: 16566899
Behav Brain Sci. 2013 Dec;36(6):661-79
pubmed: 24304775
Physiol Rev. 2015 Jul;95(3):853-951
pubmed: 26109341
Biol Psychiatry. 2005 Feb 15;57(4):319-27
pubmed: 15705346
Nat Neurosci. 2005 Jun;8(6):805-12
pubmed: 15908948
J Neurophysiol. 1998 Jul;80(1):1-27
pubmed: 9658025
Annu Rev Psychol. 2001;52:397-422
pubmed: 11148311
Psychopharmacology (Berl). 2007 Apr;191(3):483-95
pubmed: 17119929
Front Behav Neurosci. 2010 Nov 04;4:170
pubmed: 21120145
Neurosci Biobehav Rev. 2011 Jan;35(3):537-55
pubmed: 20603146
J Neurophysiol. 2010 Jul;104(1):313-21
pubmed: 20463204
J Neurosci. 2007 May 2;27(18):4826-31
pubmed: 17475790
J Neurosci. 2008 Jul 30;28(31):7837-46
pubmed: 18667616
Behav Neurosci. 2000 Jun;114(3):468-83
pubmed: 10883798
Science. 1983 Apr 22;220(4595):431-3
pubmed: 6836286
Front Neurosci. 2011 Jun 21;5:81
pubmed: 21734862
Neuron. 2010 Dec 9;68(5):815-34
pubmed: 21144997
Neuroscience. 1991;41(1):1-24
pubmed: 1676137
J Neurosci. 2010 Oct 6;30(40):13525-36
pubmed: 20926678
J Neurosci. 1996 Mar 1;16(5):1936-47
pubmed: 8774460
Proc Natl Acad Sci U S A. 2009 May 5;106(18):7281-8
pubmed: 19342487
Trends Neurosci. 2009 Jun;32(6):321-8
pubmed: 19446348
Brain Res Brain Res Rev. 1998 Dec;28(3):309-69
pubmed: 9858756
J Cereb Blood Flow Metab. 1996 Jan;16(1):7-22
pubmed: 8530558
Neural Netw. 2002 Jun-Jul;15(4-6):731-41
pubmed: 12371523
Neuroimage. 2006 Jun;31(2):790-5
pubmed: 16487726
Neuron. 2015 Feb 4;85(3):512-8
pubmed: 25654257
Neuroscience. 2000;96(4):651-6
pubmed: 10727783
Biol Mood Anxiety Disord. 2013 Jun 19;3(1):12
pubmed: 23782813
Neuron. 2002 Oct 10;36(2):265-84
pubmed: 12383781
J Neurophysiol. 1990 Mar;63(3):607-24
pubmed: 2329364
Nat Neurosci. 2003 Sep;6(9):974-80
pubmed: 12925855
Trends Neurosci. 2003 Aug;26(8):423-8
pubmed: 12900173
Front Hum Neurosci. 2013 Jun 11;7:262
pubmed: 23781185
Nat Neurosci. 2002 Feb;5(2):97-8
pubmed: 11802175
J Neurosci. 2011 May 25;31(21):7867-75
pubmed: 21613500
Trends Neurosci. 2012 Jan;35(1):68-77
pubmed: 22177980
Nature. 1998 May 21;393(6682):266-8
pubmed: 9607763
Brain Res Rev. 2007 Dec;56(2):283-321
pubmed: 17905440
Psychol Rev. 1967 May;74(3):151-82
pubmed: 5342881
J Neurosci. 2010 Aug 11;30(32):10692-702
pubmed: 20702700
J Neurosci. 2010 Dec 8;30(49):16585-600
pubmed: 21147998
Psychopharmacology (Berl). 2007 Apr;191(3):391-431
pubmed: 17072591
J Neurosci. 1993 Mar;13(3):900-13
pubmed: 8441015
Neural Netw. 2006 Oct;19(8):1302-14
pubmed: 16949252
Psychopharmacology (Berl). 2007 Apr;191(3):507-20
pubmed: 17031711
AJR Am J Roentgenol. 1986 Jul;147(1):103-10
pubmed: 3487201
PLoS One. 2006 Dec 20;1:e103
pubmed: 17183636
Brain Res Brain Res Rev. 1999 Dec;31(1):6-41
pubmed: 10611493
J Cogn Neurosci. 1997 May;9(3):392-408
pubmed: 23965014
Psychopharmacology (Berl). 2007 Apr;191(3):433-7
pubmed: 16977476
Neuron. 2003 Apr 24;38(2):329-37
pubmed: 12718865
Biol Psychiatry. 1998 May 15;43(10):713-22
pubmed: 9606524
Nat Rev Neurosci. 2016 Mar;17(3):183-95
pubmed: 26865020
Am J Psychiatry. 1991 Dec;148(12):1638-46
pubmed: 1957925
Neuron. 2015 May 6;86(3):646-64
pubmed: 25950633
Neuroimage. 2006 Jul 1;31(3):1116-28
pubmed: 16545965
J Neurophysiol. 2006 Jan;95(1):301-10
pubmed: 16192329
J Magn Reson Imaging. 1995 Sep-Oct;5(5):554-60
pubmed: 8574041
Science. 1997 Mar 14;275(5306):1593-9
pubmed: 9054347
Neuron. 2005 Jul 7;47(1):129-41
pubmed: 15996553
J Neurosci. 2001 Apr 15;21(8):2793-8
pubmed: 11306631
Neuroimage. 2002 Jan;15(1):252-64
pubmed: 11771993
Nat Neurosci. 2008 Aug;11(8):966-73
pubmed: 18660807
Neuron. 2003 Apr 24;38(2):339-46
pubmed: 12718866
Curr Biol. 2014 Jan 6;24(1):56-62
pubmed: 24332545
Neuron. 2012 Nov 8;76(3):470-85
pubmed: 23141060

Auteurs

Roberto Viviani (R)

Institute of Psychology, University of Innsbruck, 6020, Innsbruck, Austria. roberto.viviani@uibk.ac.at.
Department of Psychiatry and Psychotherapy III, University of Ulm, 89075, Ulm, Germany. roberto.viviani@uibk.ac.at.

Lisa Dommes (L)

Department of Psychiatry and Psychotherapy III, University of Ulm, 89075, Ulm, Germany.

Julia Bosch (J)

Department of Psychiatry and Psychotherapy III, University of Ulm, 89075, Ulm, Germany.

Michael Steffens (M)

Research Division, Federal Institute for Drugs and Medical Devices (BfArM), 53175, Bonn, Germany.

Anna Paul (A)

Research Division, Federal Institute for Drugs and Medical Devices (BfArM), 53175, Bonn, Germany.

Katharina L Schneider (KL)

Research Division, Federal Institute for Drugs and Medical Devices (BfArM), 53175, Bonn, Germany.

Julia C Stingl (JC)

Institute of Clinical Pharmacology, University Hospital of RWTH Aachen, Aachen, Germany.

Petra Beschoner (P)

Department of Psychosomatic Medicine and Psychotherapy, University of Ulm, 89075, Ulm, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH